search results for
View all search results
Home
Contact
Help
Print View
Store page
Deutsch
RSS
Download Report
Font Size
The Fresenius group
To our shareholders
Fresenius group in figures (U.S. GAAP)
Summary of the fiscal year
Fresenius share
Stock markets
Capital structure
Dividend
Shareholder structure
Share key data
Analyst recommendations
Investor relations
Business segments
Fresenius Medical Care
Fresenius Kabi
Fresenius Helios
Fresenius Vamed
Transparency & Governance
Report of the Supervisory Board
Corporate Governance Declaration
Group Management and Supervision Structure and Corporate Bodies
Group Management and Supervision Structure
Shareholders
Annual General Meeting
Management Board and Supervisory Board Procedures
Composition and Procedures of the Supervisory Board Committees
Relevant Disclosures on Corporate Governance Practices
Compliance
Risk Management and Control System
German Corporate Governance and Declaration of Conformity
Further Information on Corporate Governance
Diversity
Legal relationships with members of the Corporate Bodies
Disclosures on directors’ dealings and shareholdings in 2013
Transparency and Communication
Financial accounting and reporting
Compensation Report
Compensation of the Management Board
Commitments to members of the Management Board in the event of the termination of their appointment
Miscellaneous
Compensation of the Supervisory Board
Directors & Officers Insurance
Boards
Supervisory board Fresenius SE & Co. KGaA
Committees of the supervisory board
Management Board Fresenius Management SE
Supervisory Board Fresenius Management SE
Management Report
Fundamental information about the group
The group’s business model
Management and control
Key products and services
Important markets and competitive position
Legal and economic factors
Capital, shareholders, articles of association
Goals and strategy
Corporate performance criteria
Research and development
Fresenius Medical Care
Fresenius Kabi
Employees
Human Resources Management
Personnel Development
Personnel Marketing
Vocational Training Management
Profit-Sharing Scheme and Stock Option Plan
Procurement
Fresenius Medical Care
Fresenius Kabi
Fresenius Helios
Fresenius Vamed
Quality management
Fresenius Medical Care
Fresenius Kabi
Fresenius Helios
Fresenius Vamed
Responsibility, environmental management, sustainability
Fresenius Medical Care
Fresenius Kabi
Fresenius Helios
Fresenius Vamed
Sales, marketing, and logistics
Report on economic position
Health care industry
The dialysis market
The market for infusion therapy and clinical nutrition, intravenously administered drugs, medical devices, and transfusion technology
The German hospital market
The market for Projects and services for hospitals and other health care facilities
Overall business development
The Management Board’s assessment of the effect of general economic developments and those in the health care sector for Fresenius
Significant factors affecting operating performance
The Management Board’s assessment of the business results
Comparison of the actual business results with the forecasts
Results of operations, financial position, assets and liabilities
Results of operations
Financial position
Assets and liabilities
Corporate rating
Subsequent events
Overall assessment of the business situation
Outlook
General and mid-term outlook
Future markets
Health care sector and markets
Group sales and earnings
Sales and earnings by business segment
Financing
Investments
Procurement
Research and development
Corporate structure and organization
Planned changes in human resources and the social area
Dividend
Opportunities and Risk Report
Opportunities management
Risk management
Internal financial reporting controls
Risk areas
General Economic Risks
Risks in the General Operating Framework
Risks in the Health Care Sector
Operating Risks
Assessment of overall risk
Financial Statements
Consolidated statement of income
Consolidated statement of comprehensive income
Consolidated statement of financial position
Consolidated statement of cash flows
Consolidated statement of changes in equity
Consolidated segment reporting
Notes
General notes
1. Principles
2. Acquisitions, divestitures and investments
Notes on the consolidated statement of income
3. Special items
4. Sales
5. Cost of sales
6. Cost of materials
7. Personnel expenses
8. Selling, general and administrative expenses
9. Investment gain
10. Net interest
11. Other financial result
12. Taxes
13. Earnings per share
Notes on the consolidated statement of financial position
14. Cash and cash equivalents
15. Trade accounts receivable
16. Inventories
17. Other current and non-current assets
18. Property, plant and equipment
19. Goodwill and other intangible assets
20. Accrued expenses
21. Other liabilities
22. Debt and capital lease obligations
23. Senior Notes
24. Pensions and similar obligations
25. Noncontrolling interest
26. Fresenius SE & Co. KGaA shareholders’ equity
27. Other comprehensive income (loss)
Other notes
28. Commitments and contingent liabilities
29. Financial instruments
30. Supplementary information on capital management
31. Supplementary information on the consolidated statement of cash flows
32. Notes on the consolidated segment reporting
33. Stock options
34. Related party transactions
35. Subsequent events
Notes in accordance with the German Commercial Code (HGB)
36. Compensation of the Management Board and the Supervisory Board
37. Auditor’s fees
38. Corporate Governance
39. Proposal for the distribution of earnings
40. Responsibility statement
Auditor’s Report
Consolidated statement of income
Consolidated statement of comprehensive income
Consolidated statement of financial position
Consolidated statement of cash flows
Consolidated statement of changes in equity
Consolidated segment reporting
Notes
General notes
1. Principles
2. Acquisitions, divestitures and investments
Notes on the consolidated statement of income
3. Special items
4. Sales
5. Cost of sales
6. Cost of materials
7. Personnel expenses
8. Selling, general and administrative expenses
9. Investment gain
10. Net interest
11. Other financial result
12. Taxes
13. Earnings per share
Notes on the consolidated statement of financial position
14. Cash and cash equivalents
15. Trade accounts receivable
16. Inventories
17. Other current and non-current assets
18. Property, plant and equipment
19. Goodwill and other intangible assets
20. Accrued expenses
21. Other liabilities
22. Debt and capital lease obligations
23. Senior Notes
24. Pensions and similar obligations
25. Noncontrolling interest
26. Fresenius SE & Co. KGaA shareholders’ equity
27. Other comprehensive income (loss)
Other notes
28. Commitments and contingent liabilities
29. Financial instruments
30. Supplementary information on capital management
31. Supplementary information on the consolidated statement of cash flows
32. Notes on the consolidated segment reporting
33. Stock options
34. Related party transactions
35. Subsequent events
Notes in accordance with the German Commercial Code (HGB)
36. Compensation of the Management Board and the Supervisory Board
37. Auditor’s fees
38. Corporate Governance
39. Proposal for the distribution of earnings
40. Responsibility statement
Auditor’s Report
Financial Statements
>
Notes
>
Other notes
>
32. Notes on the consolidated segment reporting
32. Notes on the consolidated segment reporting
Back to:
31. Supplementary information on the consolidated statement of cash flows
Continue reading:
33. Stock options
